TRANSCATHETER CLOSURE IS AN EFFECTIVE ALTERNATIVE TO SURGERY in most
patients with atrial septal defects (ASDs) of the secundum type (1, 2). Factors that decide …

This study examines the safety and efficacy of transthoracic echocardiographic (TTE)
guidance of atrial septal defect (ASD) device closure. We evaluated 74 patients for TTE …

Congenital heart disease accounted for 0.3% of US admissions in 2007, with 48% related to
atrial septal defects (ASDs). 1 More than onefourth of adult congenital heart defects are …

BackgroundThere are concerns over the outcome of device closure of secundum atrial
septal defect with special reference to erosions and aortic regurgitation. AimTo assess the …

Cardiac erosion related to transcatheter atrial septal defect closure devices is of increasing
concern. Erosion is reported to have occurred with most of currently available occluder …

Background: Due to the advances in catheter-based interventional techniques, a wide range
of heart diseases can now be treated with a purely interventional approach. Little is yet …

Aims The identification of sex differences in the prognosis of adults with a secundum atrial
septal defect (ASD2) could help tailor their clinical management, as it has in other …

Patent foramen ovale (PFO) is a common variant present in up to 25% of the population.
Atrial septal defect (ASD) is a direct communication between the 2 atrial chambers, of which …

Objectives To evaluate the feasibility and safety of percutaneous closure of complex
secundum‐type atrial septal defects (ASD) in patients with posterior‐inferior rim deficiency …

The Amplatzer septal occluder is commonly used to close secundum atrial septal defects
(ASDs). Recently, the manufacturer's recommendations have been modified with regard to …